润达医疗: 关于实施2024年度权益分派相应调整“润达转债”转股价格的公告

Core Points - The company announced an adjustment to the conversion price of its convertible bonds due to the implementation of the 2024 annual profit distribution [1][3] - The conversion price will be adjusted from 13.00 CNY per share to 12.97 CNY per share, effective from July 18, 2025 [1][4] - The convertible bonds, known as "润达转债," were issued in June 2020 with a total amount of 550 million CNY and a maturity of six years [1][2] Summary by Sections 1. Securities Suspension and Resumption - The "润达转债" will be suspended from conversion from July 10, 2025, to July 17, 2025, and will resume conversion on July 18, 2025 [1][4] 2. Conversion Price Adjustments - The conversion price has been adjusted multiple times in the past due to annual profit distributions, with the latest adjustment being from 13.00 CNY to 12.97 CNY [2][3] - The adjustment formula for the conversion price is based on the distribution of cash dividends and other equity changes [4] 3. Dividend Distribution - The company will distribute a cash dividend of 0.30 CNY per 10 shares, which is included in the conversion price adjustment [3][4]